Page 84 of 90 for 'Pharmaceutical' in Pharmaceutical

Filters

Result types

Showing 831 - 840 of 897 for "Pharmaceutical" with applied filters

Filters:

News & Analysis

Applying presumption of patent infingement against biosimilars

07 October 2024 by Gün + Partners

Gün + Partners about the presumption of patent infringement.

News & Analysis

Patenting AI-driven drug compound screening inventions in China

01 August 2024 by Wanhuida Intellectual Property

Rui Wang of Wanhuida Intellectual Property says inventors should focus on improving AI systems’ transparency and predictability to enhance their patentability and identifies a challenge resulting from the interdisciplinary techniques involved in examination

News & Analysis

Eisenführ Speiser strengthens patent practice in the fields of chemistry, biochemistry and pharmacy at the Munich and Hamburg offices

16 July 2024 by Eisenführ Speiser

The two partners Dr André Guder and Dr Martin Nohlen are moving from the renowned law firm Uexküll & Stolberg together with the associates Dr Hanna Pieper, Dr Nils Lindenmaier and Dr Johannes Heidemann.

News & Analysis

Dr. Kerstin Wolff and Tobias Matschke promoted to Counsel at Maiwald

05 July 2024 by Maiwald

Maiwald talks about Dr. Kerstin Wolff and Tobias Matschke's promotion to Counsel

News & Analysis

Yoshikawa Interviewed on Tennessee’s New AI Law, ELVIS Act

04 July 2024 by Adams and Reese

Adams and Reese Artificial Intelligence Team Leader Jin Yoshikawa was interviewed by Managing IP in a story on Tennessee’s recent passage of the ELVIS Act (Ensuring Likeness Voice and Image Security) into law on March 21, 2024.

News & Analysis

How a Multi-Pronged Legislative Approach is Curbing the Online Trade in Fakes”

04 July 2024 by Adams and Reese, Kristina Montanaro Schrader and Maia Woodhouse

Adams and Reese Global IP Partners Kristina Montanaro Schrader and Maia Woodhouse are published authors in an article featured in World Trademark Review: “United States: How a Multi-Pronged Legislative Approach is Curbing the Online Trade in Fakes.”

News & Analysis

Israeli pride: the leading patent firm in Europe, the Middle East, and Africa is from Israel

30 May 2024 by The Luzzatto Group

The Luzzatto Group talks about being the leading patent firm in Europe, the Middle East, and Africa

News & Analysis

The Luzzatto Group Wins a Landmark Ruling On Patent Term Extensions in Israel

08 April 2024 by The Luzzatto Group

Luzzatto Group talks about patent term extensions in Israel

News & Analysis

Product-By-Process Claims Must Be Examined on Standards of Novelty and Non-Obviousness

06 March 2024 by LexOrbis

Manisha Singh (Partner) and Pankaj Musyuni (Associate Partner) talk about product-by-process claims.

News & Analysis

Actual and effective term of patents and patents erroneously considered expired

29 February 2024 by Basham Ringe y Correa

Adolfo Athié, Basham, Ringe y Correa S.C. partner, talks about term of patents and patents erroneously considered expired.

Search results

Filters

Result types

Article type

Jurisdiction

Industry sector

Applying presumption of patent infingement against biosimilars

Patenting AI-driven drug compound screening inventions in China

Eisenführ Speiser strengthens patent practice in the fields of chemistry, biochemistry and pharmacy at the Munich and Hamburg offices

Dr. Kerstin Wolff and Tobias Matschke promoted to Counsel at Maiwald

Yoshikawa Interviewed on Tennessee’s New AI Law, ELVIS Act

How a Multi-Pronged Legislative Approach is Curbing the Online Trade in Fakes”

Israeli pride: the leading patent firm in Europe, the Middle East, and Africa is from Israel

The Luzzatto Group Wins a Landmark Ruling On Patent Term Extensions in Israel

Product-By-Process Claims Must Be Examined on Standards of Novelty and Non-Obviousness

Actual and effective term of patents and patents erroneously considered expired